生殖遗传学市场：按技术、应用、样本类型、最终用户、分析方法和地区划分

2025 年生殖遗传学市场规模预计为 73.1 亿美元，预计到 2032 年将达到 166.7 亿美元，2025 年至 2032 年的复合年增长率为 12.5%。

全球生殖遗传学市场是整个医疗产业中一个快速发展的领域，涵盖了旨在评估生殖健康和不孕症治疗结果的先进基因检测和筛检技术。

这个专业市场专注于基因分析服务和产品，旨在帮助医疗保健提供者、生育诊所和患者就生育计划、妊娠管理和遗传风险评估做出明智的决定。生殖遗传学整合了尖端的分子诊断、基因测序技术和生物资讯平台，以识别可能影响生育成功率和后代健康的染色体异常、遗传性疾病和基因疾病。

该市场涵盖了各种调查方法胚胎着床前遗传学检测 (PGT)、非侵入性产前检测 (NIPT)、带因者筛检、基因咨询服务等。随着世界各地的医疗保健系统越来越重视个人化和预防性医疗，生殖遗传学已成为现代不孕症治疗和产前护理通讯协定的关键组成部分。

市场动态

全球生殖遗传学市场的主要驱动力是几个关键因素，这些因素持续推动其在已开发和新兴医疗保健市场的扩张。遗传疾病和染色体异常的日益普遍，以及全球孕产妇人口老化的趋势，显着增加了对全面基因筛检服务的需求。

高龄生产，会增加遗传併发症的风险，因此医疗机构建议进行常规基因检测。次世代定序（ NGS）、微阵列分析和基于人工智慧的诊断平台等技术的进步，显着提高了检测的准确性，同时降低了成本和缩短了周转时间，使更多患者能够获得这些服务。

随着医护人员和病患对早期基因检测益处的认识不断提高，生育诊所和医疗机构的基因检测普及率也不断提高。然而，仍有许多阻碍因素，例如先进基因检测程序的高昂费用，这可能会限制发展中国家患者或缺乏全面医疗保险的患者获得检测机会。

各国复杂的监管规定和核准流程差异可能会阻碍新技术进入市场，并延迟产品上市。此外，围绕基因检测的伦理问题，包括基因歧视和基因资讯隐私等问题，可能会让某些患者群体犹豫不决。

本报告的主要特点

• 本报告对全球生殖遗传学市场进行了详细分析，并给出了预测期（2025-2032 年）的市场规模和复合年增长率，以 2024 年为基准年。
• 它还重点介绍了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的关键见解。
• 全球生殖遗传学市场的主要企业将根据以下参数进行分析，例如公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告提供的见解将使负责人和企业经营团队能够就未来的产品发布、合作关係、市场扩张和行销策略做出明智的决策。
• 《全球生殖遗传学市场》报告涵盖了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过各种用于分析全球生殖遗传学市场的策略矩阵，更轻鬆地做出决策。

目录

第一章 分析目标与先决条件

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章：市场动态、监管与趋势分析

• 市场动态
• 司机
• 抑制因素
• 机会
• 影响分析
• 重大进展
• 监管情景
• 产品发布/核准
• PEST分析
• 波特五力分析
• 企业合併情景
• 产业趋势

4. 全球生殖遗传学市场（按技术划分）（2020-2032 年）

• 介绍
• 胚胎着床前遗传学检测（PGT）
• 携带者筛检
• 产前基因检测
• 新生儿基因检测

5. 全球生殖遗传学市场按应用领域划分（2020-2032 年）

• 介绍
• 不孕症治疗及试管婴儿项目
• 遗传疾病风险评估
• 染色体异常检测
• 胎儿健康筛检
• 遗传疾病的诊断
• 復发性流产的调查

6. 全球生殖遗传市场（依产品类型划分）（2020-2032 年）

• 介绍
• 设备和系统
• 序列器
• PCR系统
• 微阵列平台
• 耗材和试剂
• DNA萃取试剂套件
• 扩增试剂
• 杂合反应探针
• 软体和服务
• 基因数据分析工具
• 咨询及翻译服务

7. 全球生殖遗传学市场（按样本类型划分）（2020-2032 年）

• 介绍
• 胚胎
• 羊水
• 母体血
• 口腔拭子
• 脐带血

8. 全球生殖遗传市场（以最终用户划分）（2020-2032 年）

• 介绍
• 不孕症诊所/试管婴儿中心
• 医院和诊断实验室
• 分析和学术机构
• 遗传咨询中心

9. 全球生殖遗传市场分析方法（2020-2032 年）

• 介绍
• 次世代定序（NGS）
• 聚合酵素链锁反应（PCR）
• 萤光原位杂合反应（FISH）
• 比较基因组杂合反应（CGH）
• 微阵列分析

10. 全球生殖遗传市场（按地区划分）（2020-2032 年）

• 介绍
• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中非

第十一章 竞争格局

• Illumina
• Thermo Fisher Scientific
• Roche Diagnostics
• QIAGEN
• Agilent Technologies
• Revvity（PerkinElmer）
• Bio-Rad Laboratories
• Pacific Biosciences
• Oxford Nanopore Technologies
• MGI Tech
• CooperSurgical
• Hamilton Thorne
• Vitrolife
• Takara Bio
• Promega Corporation

第十二章 分析师建议

• 《命运之轮》
• 分析师观点
• Coherent Opportunity Map (COM)

第十三章 参考文献与分析方法

• 参考
• 分析方法
• 关于 Coherent Market Insights

Reproductive Genetics Market is estimated to be valued at USD 7.31 Bn in 2025 and is expected to reach USD 16.67 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2032.

The global reproductive genetics market represents a rapidly evolving segment within the broader healthcare industry, encompassing advanced genetic testing and screening technologies designed to assess reproductive health and fertility outcomes.

This specialized market focuses on genetic analysis services and products that help healthcare providers, fertility clinics, and patients make informed decisions regarding reproductive planning, pregnancy management, and genetic risk assessment. Reproductive genetics integrates cutting-edge molecular diagnostics, genomic sequencing technologies, and bioinformatics platforms to identify chromosomal abnormalities, genetic disorders, and hereditary conditions that may impact reproductive success or offspring health.

The market encompasses various testing methodologies including preimplantation genetic testing (PGT), non-invasive prenatal testing (NIPT), carrier screening, and genetic counseling services. As healthcare systems worldwide increasingly prioritize personalized medicine and preventive care, reproductive genetics has emerged as a critical component in modern fertility treatments and prenatal care protocols.

Market Dynamics

The global reproductive genetics market is primarily driven by several compelling factors that continue to fuel its expansion across developed and emerging healthcare markets. The increasing prevalence of genetic disorders and chromosomal abnormalities, combined with rising maternal age trends globally, has significantly heightened the demand for comprehensive genetic screening services.

Advanced maternal age, particularly pregnancies after 35 years, carries elevated risks of genetic complications, driving healthcare providers to recommend routine genetic testing protocols. Technological breakthroughs in next-generation sequencing (NGS), microarray analysis, and artificial intelligence-powered diagnostic platforms have substantially improved testing accuracy while reducing costs and turnaround times, making these services more accessible to broader patient populations.

Growing awareness among healthcare professionals and patients regarding the benefits of early genetic detection has fostered increased adoption rates across fertility clinics and healthcare institutions. However, the market faces notable restraints including high costs associated with advanced genetic testing procedures, which may limit accessibility for patients in developing regions or those without comprehensive insurance coverage.

Regulatory complexities and varying approval processes across different countries can impede market entry for new technologies and delay product launches. Additionally, ethical concerns surrounding genetic testing, including issues related to genetic discrimination and privacy of genetic information, may create hesitancy among certain patient demographics.

Key Features of the Study

• This report provides in-depth analysis of the global reproductive genetics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global reproductive genetics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Agilent Technologies, Revvity (PerkinElmer), Bio-Rad Laboratories, Pacific Biosciences, Oxford Nanopore Technologies, MGI Tech, CooperSurgical, Hamilton Thorne, Vitrolife, Takara Bio, and Promega Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global reproductive genetics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global reproductive genetics market

Market Segmentation

• Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • Preimplantation Genetic Testing (PGT)
  • PGT-A (Aneuploidy)
  • PGT-M (Monogenic Disorders)
  • PGT-SR (Structural Rearrangements)
  • Carrier Screening
  • Targeted Mutation Panels
  • Expanded Carrier Screening
  • Prenatal Genetic Testing
  • Non-Invasive Prenatal Testing (NIPT)
  • Invasive Testing (Amniocentesis, Chorionic Villus Sampling)
  • Newborn Genetic Testing
  • Whole Exome Sequencing
  • Targeted Gene Panels
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Infertility and IVF Programs
  • Genetic Disease Risk Assessment
  • Chromosomal Abnormality Detection
  • Fetal Health Screening
  • Inherited Disorder Diagnosis
  • Recurrent Pregnancy Loss Investigation
• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Instruments and Systems
  • Sequencers
  • PCR Systems
  • Microarray Platforms
  • Consumables and Reagents
  • DNA Extraction Kits
  • Amplification Reagents
  • Hybridization Probes
  • Software and Services
  • Genetic Data Analysis Tools
  • Counseling and Interpretation Services
• Sample Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Embryo
  • Amniotic Fluid
  • Maternal Blood
  • Buccal Swab
  • Cord Blood
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Fertility Clinics and IVF Centers
  • Hospitals and Diagnostic Laboratories
  • Research and Academic Institutes
  • Genetic Counseling Centers
• Methodology Insights (Revenue, USD Bn, 2020 - 2032)
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence In Situ Hybridization (FISH)
  • Comparative Genomic Hybridization (CGH)
  • Microarray Analysis
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Illumina
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • QIAGEN
  • Agilent Technologies
  • Revvity (PerkinElmer)
  • Bio-Rad Laboratories
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • MGI Tech
  • CooperSurgical
  • Hamilton Thorne
  • Vitrolife
  • Takara Bio
  • Promega Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Reproductive Genetics Market, By Technology
  • Global Reproductive Genetics Market, By Application
  • Global Reproductive Genetics Market, By Product Type
  • Global Reproductive Genetics Market, By Sample Type
  • Global Reproductive Genetics Market, By End User
  • Global Reproductive Genetics Market, By Methodology
  • Global Reproductive Genetics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Reproductive Genetics Market, By Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Preimplantation Genetic Testing (PGT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • PGT-A (Aneuploidy)
    • PGT-M (Monogenic Disorders)
    • PGT-SR (Structural Rearrangements)
• Carrier Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Targeted Mutation Panels
    • Expanded Carrier Screening
• Prenatal Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Non-Invasive Prenatal Testing (NIPT)
    • Invasive Testing (Amniocentesis, Chorionic Villus Sampling)
• Newborn Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Whole Exome Sequencing
    • Targeted Gene Panels

5. Global Reproductive Genetics Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Infertility and IVF Programs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genetic Disease Risk Assessment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chromosomal Abnormality Detection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Fetal Health Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inherited Disorder Diagnosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Recurrent Pregnancy Loss Investigation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Reproductive Genetics Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Instruments and Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sequencers
• PCR Systems
• Microarray Platforms
• Consumables and Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• DNA Extraction Kits
• Amplification Reagents
• Hybridization Probes
• Software and Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genetic Data Analysis Tools
• Counseling and Interpretation Services

7. Global Reproductive Genetics Market, By Sample Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Embryo
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Amniotic Fluid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Maternal Blood
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Buccal Swab
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cord Blood
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Reproductive Genetics Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Fertility Clinics and IVF Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hospitals and Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research and Academic Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genetic Counseling Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Reproductive Genetics Market, By Methodology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Next-Generation Sequencing (NGS)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Polymerase Chain Reaction (PCR)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Fluorescence In Situ Hybridization (FISH)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Comparative Genomic Hybridization (CGH)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Microarray Analysis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Reproductive Genetics Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Methodology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Illumina
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• QIAGEN
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Revvity (PerkinElmer)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pacific Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Oxford Nanopore Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• MGI Tech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CooperSurgical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hamilton Thorne
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Vitrolife
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Takara Bio
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Promega Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us